Bénédict G. F. Hentsch
Directeur/Bestuurslid bij University of St. Gallen
Profiel
Bénédict G.
F.
Hentsch is the founder.
He founded One Swiss Bank SA in 2004 and served as the Chairman from 2011 to 2014.
Currently, he holds the position of Director at the University of St. Gallen and AB2 Bio SA. In the past, he worked as a Director at Schweizerische Rückversicherungs-Gesellschaft AG from 1993 to 2009 and as a Board Member at Fairfield Greenwich Advisors LLC.
He also served as Haftender at Darier Hentsch & Cie from 1985 to 2000.
Mr. Hentsch obtained his undergraduate degree from the University of St. Gallen in 1972 and later pursued graduate studies at the same institution.
Actieve functies van Bénédict G. F. Hentsch
Bedrijven | Functie | Begin |
---|---|---|
University of St. Gallen | Directeur/Bestuurslid | - |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Bénédict G. F. Hentsch
Bedrijven | Functie | Einde |
---|---|---|
One Swiss Bank SA (Switzerland)
One Swiss Bank SA (Switzerland) Investment ManagersFinance Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million. | Oprichter | 30-01-2014 |
Schweizerische Rückversicherungs-Gesellschaft AG
Schweizerische Rückversicherungs-Gesellschaft AG Insurance Brokers/ServicesFinance Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland. | Directeur/Bestuurslid | 13-03-2009 |
Darier Hentsch & Cie | Corporate Officer/Principal | 01-10-2000 |
Fairfield Greenwich Advisors LLC
Fairfield Greenwich Advisors LLC Investment ManagersFinance Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore. | Directeur/Bestuurslid | - |
Opleiding van Bénédict G. F. Hentsch
University of St. Gallen | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Schweizerische Rückversicherungs-Gesellschaft AG
Schweizerische Rückversicherungs-Gesellschaft AG Insurance Brokers/ServicesFinance Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland. | Finance |
Darier Hentsch & Cie | Finance |
One Swiss Bank SA (Switzerland)
One Swiss Bank SA (Switzerland) Investment ManagersFinance Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million. | Finance |
Fairfield Greenwich Advisors LLC
Fairfield Greenwich Advisors LLC Investment ManagersFinance Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |